BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22456267)

  • 21. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
    Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
    Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
    Wang DG; Johnston CF; Buchanan KD
    Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
    Stevenson R; Libutti SK; Saif MW
    JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
    Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
    Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].
    Hörsch D; Sayeg Y; Bonnet R; Kaemmerer D; Presselt N; Baum RP
    Pneumologie; 2012 Jan; 66(1):44-8. PubMed ID: 22250054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
    Arnold CN; Sosnowski A; Blum HE
    Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.
    Stevenson M; Lines KE; Thakker RV
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):525-548. PubMed ID: 30098714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
    Gupta S; Engstrom PF; Cohen SJ
    Clin Colorectal Cancer; 2011 Dec; 10(4):298-309. PubMed ID: 21813338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
    Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
    [No Abstract]   [Full Text] [Related]  

  • 33. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
    Gloesenkamp C; Nitzsche B; Lim AR; Normant E; Vosburgh E; Schrader M; Ocker M; Scherübl H; Höpfner M
    Int J Oncol; 2012 May; 40(5):1659-67. PubMed ID: 22246317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
    Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
    Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
    Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
    Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
    Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.
    Lubensky IA; Zhuang Z
    Endocr Pathol; 2007; 18(3):156-62. PubMed ID: 18041590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 in human neuroendocrine: tumorigenesis.
    Chung DC
    Ann N Y Acad Sci; 2004 Apr; 1014():209-17. PubMed ID: 15153436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
    Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
    Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.